Treatment of periodontal disease in a patient with Ehlers-Danlos syndrome. A case report and literature review

Journal of Periodontology

Volumn 73, Issue 5, 2002, Pages 564-570

  Perez, Luis A ^a   Al Shammari, Khalaf F ^a   Giannobile, William V ^a   Wang, Hom Lay ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cross linking; Ehlers Danlos syndrome; Genetic counseling; Gingival crevicular fluid analysis; Periodontal diseases etiology

Indexed keywords

AMOXICILLIN; CELECOXIB; CLAVULANATE POTASSIUM; DEXAMETHASONE; DIPHENHYDRAMINE; DOXYCYCLINE HYCLATE; LORAZEPAM; NYSTATIN; PYRIDINOLINE; SERTRALINE;

ADULT; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROSS LINKING; DIAGNOSTIC TEST; EHLERS DANLOS SYNDROME; ELASTICITY; FEMALE; GENETIC COUNSELING; HISTOPATHOLOGY; HUMAN; MEDICAL CARE; MEDICAL LITERATURE; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTICS; RETROSPECTIVE STUDY; SIBLING; SKIN; WELLBEING;

ALVEOLAR BONE LOSS; COLLAGEN; COLLAGEN TYPE I; EHLERS-DANLOS SYNDROME; FEMALE; FUSOBACTERIUM NUCLEATUM; GENETIC COUNSELING; GINGIVAL CREVICULAR FLUID; GINGIVAL HYPERPLASIA; GINGIVITIS; HUMANS; MIDDLE AGED; PEPTIDES; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL DISEASES; PERIODONTAL POCKET;

EID: 0036114420     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2002.73.5.564     Document Type: Article

References (48)

1. Ehlers-Danlos Syndromes: Revised nosology
2. Ehlers-Danlos syndrome
3. Molecular mechanisms of connective tissue abnormalities in the Ehlers-Danlos syndrome
4. Ehlers-Danlos syndrome: Recent advances and current understanding of the clinical and genetic heterogeneity
5. Ehlers-Danlos syndrome identified from periodontal findings: Case report
6. Ehlers-Danlos syndrome presenting with juvenile destructive periodontitis
7. Oral manifestations of Ehlers-Danlos syndrome type VII: Histological examination of a primary tooth
8. Ehlers Danlos syndrome type I with novel dental features
9. Gingival fibrinoid deposits in Ehlers-Danlos syndrome
10. Detection of high-risk groups and individuals for periodontal diseases. Systemic predisposition and markers of general health
11. Ehlers-Danlos syndrome
12. Ehlers-Danlos syndrome (in Czech)
13. The Ehlers-Danlos syndrome. A report of the oral and haematological findings in nine cases
14. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS
15. Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome type IV and alterations in the size and distribution of the major collagen fibrils of the dermis
16. 2 and epidermal growth factor
17. Ehlers-Danlos syndrome type IV: A subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen
18. Ehlers-Danlos syndrome type IV: A multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen
19. Ehlers-Danlos syndrome type VI: Lysyl hydroxylase deficiency due to a novel point mutation (W612C)
20. Ehlers-Danlos Syndrome Type VI (EDS VI): Problems of diagnosis and management
21. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI
22. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene
23. Ehlers-Danlos syndrome type VII: Clinical features and molecular defects
24. Clinical, morphological, and biochemical phenotype of a new case of Ehlers-Danlos syndrome type VIIC
25. Ehlers-Danlos syndrome type VIII
26. A new variant of Ehlers-Danlos syndrome: An autosomal dominant disorder of fragile skin, abnormal scarring and generalized periodontitis
27. Ehlers-Danlos syndrome (type VIII)
28. Ehlers-Danlos syndrome, type VIII presenting with periodontitis and prolonged bleeding time
29. Sporadic Ehlers-Danlos syndrome with neurologic, cardiac and dental involvement
30. Dental implications in Ehlers-Danlos syndrome. A case report
31. Ehlers-Danlos type VIII. Review of the literature
32. A case of Ehlers-Danlos syndrome (in Japanese)
33. Ehlers-Danlos syndrome: A case report
34. Phenotypic overlap of Ehlers-Danlos syndrome types IV and VIII
35. Aerobic and anaerobic bacteria in deep infections after total hip arthroplasty: Differential diagnosis between infectious and non-infectious loosening
36. Septic discitis
37. Gram-negative species associated with active destructive periodontal lesions
38. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases
39. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
40. Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis
41. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption
42. Evaluation of bone loss and the serum markers of bone metabolism in patients with hyperparathyroidism
43. Urinary excretion of pyridinium crosslinks: A new marker of bone resorption in metabolic bone disease
44. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs
45. Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontol pathogens in periodontitis
46. Collagen peptides in osteogenesis imperfecta, idiopathic juvenile osteoporosis and Ehlers-Danlos syndrome
47. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis
48. Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels